Literature DB >> 3122679

Severe hypophosphatemia in hospitalized patients.

J Halevy1, S Bulvik.   

Abstract

Severe hypophosphatemia (serum phosphorus less than or equal to 0.48 mmol/L [less than or equal to 1.5 mg/dL]) was found in 120 patients admitted to a major university hospital, during a period of 16 months. Fifty-one patients (42.5%) developed hypophosphatemia postoperatively. Medications known to precipitate hypophosphatemia were a causative factor in 82% of the patients, with glucose administered intravenously, antacids, diuretics, and steroids being the most common agents associated with profound hypophosphatemia. Gram-negative septicemia was observed in 16 patients, and it was the second most common cause of severe hypophosphatemia. The mortality rate was 20% in patients with a serum phosphorus concentration between 0.36 and 0.48 mmol/L (1.1 and 1.5 mg/dL) (group A) and 30% in patients with a serum phosphorus concentration of less than or equal to 0.32 mmol/L (less than or equal to 1.0 mg/dL) (group B). The cause of death and its temporal association with the lowest observed values of phosphorus concentration indicate that severe hypophosphatemia might be a contributory factor to mortality. Our data indicate that severe hypophosphatemia in hospitalized patients is the result of a combination of factors. Surgery, followed by a period of fasting with intravenous administration of glucose, and gram-negative septicemia are the most common causes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3122679

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  Hypophosphataemic neuropathy in a patient who received intravenous hyperalimentation.

Authors:  Yohei Iguchi; Keiko Mori; Haruki Koike; Kazuo Mano; Yoji Goto; Takashi Kato; Tomonobu Nakano; Daisuke Furukawa; Gen Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10       Impact factor: 10.154

Review 2.  Clinical significance in alcoholic patients of commonly encountered laboratory test results.

Authors:  G J Magarian; L M Lucas; K L Kumar
Journal:  West J Med       Date:  1992-03

3.  NSAID-induced symptomatic hypophosphataemia.

Authors:  Morten Sommerfeldt Skeid; Ulrik Pedersen-Bjergaard; Peter Lommer Kristensen; Lisbet Brandi
Journal:  Br J Clin Pharmacol       Date:  2016-08-10       Impact factor: 4.335

Review 4.  Refeeding syndrome : physiological background and practical management.

Authors:  Aminda De Silva; Jeremy M D Nightingale
Journal:  Frontline Gastroenterol       Date:  2019-12-30

5.  Severe hypophosphataemia: a rare cause of postoperative muscle weakness.

Authors:  Aarti Narayan; Arun Subramanian
Journal:  BMJ Case Rep       Date:  2018-02-23

6.  Approach to the hypophosphatemic patient.

Authors:  Erik A Imel; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2012-03       Impact factor: 5.958

7.  Hypophosphataemic neuropathy during total parenteral nutrition.

Authors:  Yohei Iguchi; Keiko Mori; Haruki Koike; Kazuo Mano; Yoji Goto; Takashi Kato; Tomonobu Nakano; Gen Sobue
Journal:  BMJ Case Rep       Date:  2009-02-02

8.  High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function.

Authors:  J F Zazzo; G Troché; P Ruel; J Maintenant
Journal:  Intensive Care Med       Date:  1995-10       Impact factor: 17.440

9.  Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders.

Authors:  Thomas J Weber; L Darryl Quarles
Journal:  Curr Mol Biol Rep       Date:  2019-02-09

10.  Potentially life-threatening phosphate diabetes induced by ferric carboxymaltose injection: a case report and review of the literature.

Authors:  Xavier Vandemergel; Frédéric Vandergheynst
Journal:  Case Rep Endocrinol       Date:  2014-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.